Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Martin R and Sospedra M Sphingosine-1 phosphate and central nervous system. 2014 Curr. Top. Microbiol. Immunol. pmid:24728597
Xia P and Wadham C Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. 2011 Cytokine Growth Factor Rev. pmid:21051273
Hirahara K et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. 2010 Cytokine Growth Factor Rev. pmid:21084214
Gil PR et al. Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P₁ and S1P₃ and Smad-signalling. 2010 Cytoskeleton (Hoboken) pmid:20857421
Balczerski B et al. Analysis of sphingosine-1-phosphate signaling mutants reveals endodermal requirements for the growth but not dorsoventral patterning of jaw skeletal precursors. 2012 Dev. Biol. pmid:22185793
Phan VH et al. Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila. 2007 Dev. Biol. pmid:17706961
Wendler CC and Rivkees SA Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. 2006 Dev. Biol. pmid:16434032
Boyce BF Sphingosine-1 phosphate: a new player in osteoimmunology. 2009 Dev. Cell pmid:19289077
Fukui H et al. S1P-Yap1 signaling regulates endoderm formation required for cardiac precursor cell migration in zebrafish. 2014 Dev. Cell pmid:25313964
Chang CH and Randolph GJ Sphingosine-1-Phosphate as the Lymphocyte's Ticket to Ride and Survive. 2017 Dev. Cell pmid:28633013
Ma S et al. A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis. 2017 Dev. Cell pmid:28535372
Okae H and Iwakura Y Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. 2010 Dev. Dyn. pmid:20186915
Ohuchi H et al. Expression patterns of the lysophospholipid receptor genes during mouse early development. 2008 Dev. Dyn. pmid:18924241
MacLennan AJ et al. Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. 2000 Dev. Neurosci. pmid:10965150
Fincher J et al. G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphate. 2014 Dev. Neurosci. pmid:25138637
Nakajima C et al. The lipoprotein receptor LRP1 modulates sphingosine-1-phosphate signaling and is essential for vascular development. 2014 Development pmid:25377550
Li G et al. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. 2001 Development pmid:11566853
Mendelson K et al. Sphingosine 1-phosphate signalling. 2014 Development pmid:24346695
Edsbagge J et al. Vascular function and sphingosine-1-phosphate regulate development of the dorsal pancreatic mesenchyme. 2005 Development pmid:15689381
Pantoja M et al. Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. 2013 Development pmid:23154413
Strochlic L et al. A role for S1P signalling in axon guidance in the Xenopus visual system. 2008 Development pmid:18077591
Laychock SG et al. Endothelial differentiation gene receptors in pancreatic islets and INS-1 cells. 2003 Diabetes pmid:12882914
Sauvé M et al. Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes. 2016 Diabetes pmid:27207546
Mastrandrea LD et al. Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. 2005 Diabetes pmid:15855330
Lee SY et al. Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance. 2017 Diabetes pmid:28698261
Srinivasan S et al. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. 2008 Diabetes pmid:18003758
Rojas-Canales D et al. Local Sphingosine Kinase 1 Activity Improves Islet Transplantation. 2017 Diabetes pmid:28174291
Bautista-Pérez R et al. Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats. 2011 Diabetes Res. Clin. Pract. pmid:21775010
Fayyaz S et al. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. 2014 Diabetologia pmid:24292566
Greenspon J et al. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. 2009 Dig. Dis. Sci. pmid:18654850
Greenspon J et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. 2011 Dig. Dis. Sci. pmid:20936358
Nguyen-Tran DH et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. 2014 Dis Model Mech pmid:24077965
Pattanaik D and Postlethwaite AE A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis. 2010 Discov Med pmid:20807477
Gao Y et al. Sphingosine kinase 1 as an anticancer therapeutic target. 2015 Drug Des Devel Ther pmid:26150697
Arish M et al. Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases. 2016 Drug Discov. Today pmid:26456576
Snelder N et al. Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylation. 2014 Drug Metab. Dispos. pmid:24965813
Ryan JJ and Spiegel S The role of sphingosine-1-phosphate and its receptors in asthma. 2008 Drug News Perspect. pmid:18389100
Waeber C et al. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. 2004 Jul-Aug Drug News Perspect. pmid:15334188
Tsai HC and Han MH Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. 2016 Drugs pmid:27318702
Sensken SC and Gräler MH [Sphingolipids and their medical impact]. 2009 Dtsch. Med. Wochenschr. pmid:19180419
Yangyuoru PM et al. Determination of sphingosine kinase 2 activity using fluorescent sphingosine by capillary electrophoresis. 2011 Electrophoresis pmid:21706498
Ryu J et al. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. 2006 EMBO J. pmid:17124500
Stam JC et al. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. 1998 EMBO J. pmid:9670021
Reichardt P et al. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. 2013 EMBO J. pmid:23443048
Meyer zu Heringdorf D et al. Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. 1998 EMBO J. pmid:9582276
Postma FR et al. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. 1996 EMBO J. pmid:8665846
Bünemann M et al. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. 1996 EMBO J. pmid:8896446
Pierre SC et al. PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate. 2004 EMBO J. pmid:15257286
Ponnusamy S et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. 2012 EMBO Mol Med pmid:22707406
Burnett C and Howard K Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo. 2003 EMBO Rep. pmid:12856002